InvestorsHub Logo
Followers 86
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: tech0200 post# 225290

Sunday, 07/05/2015 2:39:48 PM

Sunday, July 05, 2015 2:39:48 PM

Post# of 345698
who knows. nobody knows. Though If there was a deal it is possible it is all based upon Phase III success so it would then simply become a waiting game. In the interim of that waiting, both sides make the appropriate moves and move forward, CALICO makes a deal with Abbvie(that just so happened to be already part of the deal with PPHM per legal filings), UTSWM (for compounds..etc that become more valuable if combined with PS Targeting and TX Board of Regents already part of the patent/royalties..etc) and now Broad Institute.

Just a coincidence that this latest move, Broad Institute is part of the Star Consortium with Memorial Sloan Kettering that Peregrine just sets a deal with ? maybe....maybe not

Its funny how CALICO has been in the back of minds for months and every few months more things happen that fit perfectly with this all ending with a deal between CALICO and Peregrine

lots of puzzle pieces out there and no insider information needed to solve it

Time will tell... or Roche gets pi$$ed enough where they just make one hell of a big offer and then its out to vote for "deal or no deal"



"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline."
-- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News